Skip to main content
SpringerLink
Log in

Non-Medicinal Ingredients

  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Many drug products contain excipients which perform important functions in terms of stability, solubility and identification. Excipients should not be considered as inactive ingredients, as they have been associated with a wide range of adverse reactions in some individuals. Monitoring for excipient toxicity is important. Equally important, is the provision of non-medicinal ingredient information on packaging, patient information leaflets and prescribing information, as most excipient-related toxicity is preventable when the formulation is known.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Brown E. Patient information leaflets: a progress report. British Institute of Regulatory Affairs 8 (2): in press

  • Clarke RSJ. Epidemiology of adverse reactions in anaesthesia in the United Kingdom. Klinische Wochenschrift 60: 1003–1005, 1982

    Article  PubMed  CAS  Google Scholar 

  • Drug and Therapeutics Bulletin. Tartrazine: a yellow hazard. Drug Therapy Bulletin 19: 75, 1981

    Google Scholar 

  • Fisher AA. Dermatitis due to formaldehyde-releasing agents in cosmetics and medicaments. Cutis 22: 655, 1978

    PubMed  CAS  Google Scholar 

  • Golightly LK, Smolinske SS, Bennett ML, Sutherland III EW, Rumack BH. Pharmaceutical excipients. Medical Toxicology 3: 128–165, 1988

    Article  PubMed  CAS  Google Scholar 

  • Hoefnagels WAJ, Gerritsen EJA, Brouwer OF, Souverijn JHM. Cyclosporin encephalopathy associated with fat embolism induced by the drug’s solvent. Lancet 2: 901, 1988

    Article  PubMed  CAS  Google Scholar 

  • Murdoch RD, Pollock I, Naeem S. Tartrazine induced histamine release in vivo in normal subjects. Journal of the Royal College of Physicians, London 21: 257–261, 1987

    CAS  Google Scholar 

  • O’Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet 2: 1424–1425, 1986

    Article  PubMed  Google Scholar 

  • Rawlins MD. Spontaneous reporting of adverse reactions. I. The data. British Journal of Clinical Pharmacology 26: 1–5, 1988a

    Article  PubMed  CAS  Google Scholar 

  • Rawlins MD. Spontaneous reporting of adverse reactions. II. Uses. British Journal of Clinical Pharmacology 26: 7–11, 1988b

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Health, Medicines Control Agency, Room 1619, Market Towers, 1 Nine Elms Lane, Vauxhall, London, SW8 5NQ, United Kingdom

    Alexander W. M. Scott (Senior Medical Officer)

Authors
  1. Alexander W. M. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scott, A.W.M. Non-Medicinal Ingredients. Drug-Safety 5 (Suppl 1), 95–100 (1990). https://doi.org/10.2165/00002018-199000051-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199000051-00015

Keywords

Search

Navigation